Ozempic (Semaglutide Injection) 0.25 mg or 0.5mg Pre-filled Pen 3mL **Refrigerated Item**

Ozempic (semaglutide injection) is a medication used to treat type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by increasing insulin production and reducing the release of glucose from the liver. Ozempic is injected once a week and has been shown to help lower blood sugar levels, promote weight loss, and reduce the risk of cardiovascular events in people with type 2 diabetes. It also may have some benefits in reducing the risk of kidney disease in people with type 2 diabetes. It is important to follow your doctor's instructions and continue to monitor your blood sugar levels while taking Ozempic.

Refrigerated Item, Ships Signature Required, Next Day Air

Rx items are not returnable. 

Ozempic (semaglutide) is a once-weekly injection utilized for the management of type 2 diabetes mellitus. Developed by Novo Nordisk, Ozempic aids in glycemic control and offers the dual benefit of potential weight loss for individuals managing this chronic condition. Ozempic is available in a user-friendly pre-filled pen designed for simplicity and ease of use, ensuring patients can efficiently administer their medication with minimal effort.

Product Details and Features:

Formulation: Pre-filled pen for subcutaneous injection.
Concentration: Available in dosages of 0.25 mg and 0.5 mg per injection.
Volume: Each pen contains 3 mL of solution.
Indications: Primarily prescribed for improving blood sugar control in adults with type 2 diabetes, though it may additionally be used to reduce cardiovascular complications in patients with cardiovascular risk as per physician evaluation.
Administration: Administered once weekly, offering convenience by reducing the frequency of injections compared to daily therapies.
Storage: Store refrigerated until use; may be kept at room temperature not exceeding 86°F (30°C) for a period following first use, but always refer to specific storage instructions.

Mechanism of Action:

Ozempic works as a GLP-1 receptor agonist. By mimicking the action of the incretin hormone GLP-1, Ozempic enhances glucose-dependent insulin secretion, inhibits glucagon release, and slows gastric emptying. This triad of actions contributes comprehensively to improved glycemic control as it helps lower glucose production in the liver and diminish appetite, thus fostering weight loss.

Side Effects:

Common and mild to moderate side effects reported with Ozempic usage may include:

• Gastrointestinal Effects: Nausea, diarrhea, vomiting, abdominal pain, and constipation are the most commonly observed.
  
• Decreased Appetite: Often a correlation with the weight loss benefits seen in treatments.
  
• Injection Site Reactions: Possible mild pain or irritation.

Rare but more severe side effects need medical attention and can include:

• Pancreatitis: Severe and persistent abdominal pain could be indicative of this condition.
  
• Gallbladder Disease: Including cholelithiasis.
  
• Hypoglycemia: Especially if used in conjunction with insulin or other antidiabetic medications.
  
• Kidney Problems: Worsening of renal failure symptoms in susceptible individuals.

Warnings:

• Thyroid Tumors: Due to an observed risk in rodent studies, there is a warning regarding potential C-cell tumors in the thyroid. Not recommended for those with a family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  
• Pancreatitis Warning: Patients should discontinue use if pancreatitis is suspected.
  
• Hypersensitivity Reactions: Any signs of a severe allergic reaction necessitate discontinuation.
  
• Renal & Hepatic Function: Use with caution in patients with renal impairment or with regard to hepatic safety parameters.
  
• Pregnancy & Breastfeeding: There’s insufficient data in human pregnancy; use is recommended only if the potential benefit justifies the potential risk.

Patients should have regular consultations with their healthcare provider to monitor response and adjust dosing as appropriate. Patients with possible risk factors, existing medical conditions, or concerns should engage their physician in comprehensive discussions to ensure the safety and efficiency of their treatment pathway with Ozempic.

Brand: Novo Nordisk
NDC: 00169-4181-13
UPC: 301694181137
Dose: 0.25mg or 0.5mg
Type: Refrigerated Item